forces. In contrast, high levels of muscle mass are not required to maintain endurance exercise, and, consequently, it leads to little change in skeletal muscle mass. There is evidence to suggest that the muscle's acute response to endurance exercise is catabolic. Rates of protein synthesis are moderately reduced or unchanged (3, 6, 10) , whereas there is a concomitant increase in rates of muscle protein degradation during and in the few hours after exercise (6, 11, 16) . However, despite these acute responses to endurance exercise, muscle mass over the long term is maintained or in some cases increased (23) . This must be achieved through a period of protein anabolism in the "recovery" phase after exercise, but the roles of proteolysis and protein synthesis in this process are still to be fully elucidated.
Although it has long been recognized that exercise can lead to an acute increase in protein breakdown, there is still little knowledge about which proteolytic pathways are involved. Both Ca 2ϩ -activated (calpains) and lysosomal (cathepsins) proteases have been implicated in the exercise-induced increase in proteolysis, although this is usually in association with exerciseinduced muscle damage (29) . More recent studies suggest that the ubiquitin-proteasome pathway is also involved in the exercise-induced proteolysis (22, 27) . For example, exercise has been shown to increase proteasome activity in rat muscle (22) and the expression of one component of this pathway (ubiquitin) in human muscle (27) . However, in another study, the mRNA expression of components of the ubiquitin-proteasome pathway was reduced by passive leg cycling in spinal cord injury patients (31) . Clearly, more extensive investigations are required to clarify the role of the ubiquitin-proteasome pathway in exercise-induced alterations in protein metabolism, particularly in the postexercise recovery period. Thus, in the present study, we have measured the rates of protein turnover and the activity of the ubiquitin-proteasome pathway in rats 24 h after the final bout of an endurance exercise training regimen.
The ubiquitin-proteasome pathway is not only involved in the general turnover of the majority of cellular proteins but also plays a key role in the control of major biological events, such as cell cycle progression, transcriptional control, signal transduction, receptor downregulation, and class I antigen presentation (21) . In this pathway, polyubiquitin chains are first covalently attached to proteins that are to be degraded in a multiple-step process that requires ATP, the ubiquitin-activating enzyme (E1), and one of the ubiquitinconjugating enzymes (E2), which functions either alone or in the presence of a ubiquitin-protein ligase (E3) (21) . After polyubiquitinylation, the targeted proteins are then recognized and degraded by the 26S proteasome. The association of a proteolytic core, the 20S proteasome, with two 19S regulatory complexes forms the 26S proteasome. The 19S regulatory complex confers ATP and ubiquitin dependency to proteolysis and stimulates the proteolytic and peptidase activities of the 20S proteasome core (30) .
The dramatic muscle hypertrophy of transgenic mice overexpressing the insulin-like growth factor I (IGF-I) gene in skeletal muscle (8) has confirmed the central role of IGF in skeletal muscle proliferation and differentiation. These results, together with the reports of an exercise-induced increase in muscle IGF-I expression (12, 33) , have led to the suggestion that muscle-derived IGF-I is largely responsible for exercise-induced hypertrophy. Exogenous IGF-I administration has also been shown to reduce muscle disuse atrophy when combined with resistance exercise (24) . In the present study, we have examined whether the administration of exogenous IGF-I can augment the anabolic effect of endurance exercise in a nonatrophic model.
MATERIALS AND METHODS

Materials.
Recombinant human (rhIGF-I) and rat IGF-I were provided by Gropep (Adelaide, Australia). [U- 14 C]phenylalanine and [methyl- 14 C]casein were supplied by APBiotech (Sydney, Australia). The fluorogenic protease substrate SucLeu-Leu-Val-Tyr-7-amino-4-methylcoumarin (Suc-LLVY-AMC) and the protease inhibitors phenylmethylsulfonyl fluoride (PMSF), trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E64d), and pepstatin A were from Sigma-Aldrich (Sydney, Australia). Affiniti Research Products (Mamhead, UK) provided the proteasome inhibitor lactacystin.
Animals. The joint Animal Care and Ethics Committee of University of Technology, Sydney, and Royal North Shore Hospital, Sydney, approved the experimental protocol and the animal holding facilities. Adult male Sprague-Dawley rats, weighing ϳ200 g (Gore Hill Research Laboratories, Sydney, Australia) were placed individually in metabolic cages in a light-(lights off 200, lights on 1400) and temperature-controlled (23-25°C) environment for 7 days to acclimatize the animals to the new conditions. During this and the intervention period (exercise training and IGF-I treatment), the animals were given free access to water and rat chow. Although food intake was not measured in this study, in a subsequent study we have found that the exercise regimen used in the present study results in little alteration in ad libitum food intake (ϳ5% decrease in exercised vs. nonexercised rats). Furthermore, exercise did not influence the pattern of food intake: the quantity of food eaten in the 6 h before and 6 h after exercise.
Experimental design. The experimental protocol was an independent group factorial design, with two independent variables being exercise and rhIGF-I treatment. Two days before the start of the experiment, all rats were familiarized with running on a motorized treadmill, with nonrunning rats excluded from the study. The exercise familiarization was over 2 consecutive days: 24 m/min on day 1 (5 min) and 29 m/min on day 2 (5 min), at an incline of ϩ7.5%.
After the exercise familiarization phase, animals were randomly allocated to one of four groups: 1) an exercise and rhIGF-I-treated group; 2) an exercise and placebo-treated group; 3) a no-exercise and rhIGF-I-treated group; or 4) a no-exercise and placebo-treated group.
Exercise protocol. The exercise was performed on a human motorized treadmill (MX7, Body Builder Australia, Sydney, Australia), modified for rats. The rats exercised between 9:00 and 11:00 AM at the end of their normal, active (dark) period. The intensity and duration of the exercise were progressively increased over 5 consecutive days: day 1, 24 m/min for 30 min; day 2, 24 m/min for 45 min; day 3, 27 m/min for 45 min; day 4, 27 m/min for 60 min; and day 5, 29 m/min for 60 min. The treadmill was maintained at an incline of 7.5% for all levels of exercise. A similar exercise regimen, without an incline, has been shown to produce hypertrophic adaptations (12) . The rats were "encouraged" to maintain the exercise with an electric stimulator grid at the rear of the treadmill. The nonexercise groups spent the same amounts of time in the treadmill while it was stationary. The rats were observed at all times while they were being exercised to ensure that they were running continuously with normal gait and without significant overt signs of pain or distress. Two out of twenty rats became distressed during the fourth exercise bout, and they were withdrawn from the study. Nine animals successfully completed the exercise regimen in each of the exercise groups, and there were 10 animals in each of the nonexercise groups.
Tissue preparation. Twenty-four hours after the last exercise period (day 6 of the exercise period), the rats were anesthetized (3.6 mg pentobarbitone/kg body wt ip), and both epitrochlearis muscles were carefully dissected and placed into incubation medium for measurement of protein turnover. The weights of a number of lower limb muscles were also recorded: tibialis anterior, soleus, whole gastrocnemius, and extensor digitorum longus (EDL). Care was taken to remove the muscles from tendon to tendon, and any excess fascia was carefully trimmed away. Finally, blood (4-5 ml) was obtained by cardiac puncture, and plasma was stored for assessment of glucose and hormone levels.
For the measurement of protease activity, fresh muscle tissue (400-500 mg) was homogenized in 10 volumes of ice-cold buffer (50 mM Tris ⅐ HCl, pH 8.0, containing 10% glycerol, 1 mM EDTA, 1 mM EGTA, 50 nM E64d, 2.5 mM pepstatin A) with the use of a Polytron homogenizer (model PT10St "OD" S, Kinematica) and was centrifuged at 100,000 g for 1 h. The resulting pellet was resuspended in reaction media and used immediately.
rhIGF-I treatment. rhIGF-I was administered to the animals as a subcutaneous injection (1.0 mg/kg body wt) immediately postexercise. The IGF-I administration began on the first exercise day and continued for the 5 days of the exercise period. Animals not receiving IGF-I were given equal volumes of sterile IGF-I vehicle as a placebo (5 mM HCl, 0.5 mg/ml BSA).
Measurement of protein turnover in incubated muscles.
Epitrochlearis muscles (40-60 mg) were incubated at 37°C in a standard Krebs-Henseleit medium (120 mM NaCl, 25 mM NaHCO 3, 4.8 mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 0.5 mM CaCl 2, pH 7.4) containing 5 mM glucose, equilibrated, and maintained under pressure with O 2/CO2 (19:1). After 30 min of preincubation, the muscles were transferred to fresh medium and incubated for a further 2 h.
The rate of total mixed muscle protein synthesis was determined by incubating the muscles in a medium containing 0.5 mM [U-
14 C]phenylalanine [specific radioactivity in the medium, 500 disintegrations ⅐ min Ϫ1 (dpm) ⅐ nmol Ϫ1 ] as described previously (28) . Muscle protein mass was determined by using the bicinchoninic acid method (25) . Rates of phenylalanine incorporation were converted into tyrosine equivalents by multiplying by 0.77, the molar ratio of tyrosine to phenylalanine in rat muscle proteins (28) . Net protein breakdown was determined by measuring the rate of tyrosine release from the epitrochlearis muscles into the medium (28) . As tyrosine is not synthesized or metabolized in muscle (15) , and muscle tyrosine concentration is not altered during incubation (results not shown; Ref. 15) , tyrosine release is a measure of the degradation of all muscle proteins. However, as tyrosine released into the incubation medium can be taken up for protein synthesis, the rates of protein breakdown were calculated as the sum of the rate of protein synthesis (in tyrosine equivalents) and the rate of tyrosine release.
Proteasome activity. The chymotrypsin activity of the crude muscle extracts was determined by measuring the rate of hydrolysis of the fluorogenic peptide Suc-LLVY-AMC, as described by Farout et al. (14) . The reaction mixture (200 l) contained 50 mM Tris ⅐ HCl, pH 8.0, 1 mM dithiothreitol, 50-80 g protein, and 40 M Suc-LLVY-AMC. Incubations were performed at 37°C for 30 min. The fluorescence was continuously monitored on a RF-1501 Shimadzu spectrofluorometer (excitation 370 nm, emission 420 nm), and initial steady-state rates of hydrolysis were used. To assess the specificity of the measurements, crude muscle extracts were preincubated for 30 min at 37°C with the proteasome inhibitor lactacystin (50 M), the serine protease inhibitor PMSF (100 M), or the cysteine protease inhibitor E64d (50 M). Assays were performed in duplicate, and the mean results are presented. The variation among duplicates was Ͻ12%.
Casein degradation. The activity of the ubiquitin-proteasome-dependent proteolytic pathway in crude extracts of gastrocnemius muscles was assessed by measuring the ATPubiquitin-dependent degradation of [methyl-
14 C]casein, as previously described (19) . Muscle extracts (100 g protein) were incubated at 37°C for 45 min in the presence of 40,000 dpm [methyl- 14 C]casein, 50 mM Tris ⅐ HCl, pH 7.8, 20 mM NaCl, 2 mM dithiothreitol, and 9 mM MgCl2, in a total volume of 200 l. The incubations were performed with and without ATP (5 mM) and ubiquitin (2.5 g/ml). To assess the specificity of the hydrolysis, some muscle extracts were preincubated for 30 min at 37°C with the proteasome inhibitor lactacystin (50 M). The reactions were stopped with the addition of 500 l of 10% (wt/vol) TCA. The samples were left on ice for at least 1 h and centrifuged, and the release of acid-soluble peptides was measured by using a Tricarb Packard ␤-liquid scintillation counter. Corrections were made for radioactivity appearing in the acid-soluble supernatant after incubation of [methyl- 14 C]casein in the absence of muscle extracts. This was generally Ͻ1% of the radioactivity in the TCA-soluble supernatants from incubations with muscle extracts. Assays were performed in duplicate, and the mean results are presented. The variation among duplicates was Ͻ7%. The appearance of acid-soluble peptides was found to be linear for at least 60 min of incubation (data not shown).
Northern blot analysis. Gastrocnemius muscles were rapidly excised, frozen in liquid nitrogen, and stored at Ϫ80°C. Total RNA was extracted from frozen tissue (100-200 mg) as described (7), and 10 g were electrophoresed in 1% (wt/vol) agarose gels containing formaldehyde. RNA was vacuum transferred to a nylon membrane (GeneScreen, NEN Research Products, Boston, MA) and covalently bound to the membrane by ultraviolet cross-linking. The membranes were hybridized with cDNA probes encoding chicken polyubiquitin (1), the human ␤-1 20S proteasome subunit (2), rat 14-kDa E2 ubiquitin-conjugating enzyme (32) , and mouse 18S rRNA. The hybridizations were performed at 65°C with [
32 P]cDNA fragments labeled by random priming. After they were washed at the same temperature, the membranes were placed in a FujiFilm FLA-3000 phosphor imager (Sydney, Australia), and the radiographic signals were quantified by using the LProcess (FujiFilm) imaging software (version 1.96). The data were normalized with the corresponding 18S rRNA signals to correct for small variations in RNA loading.
Serum measurements. Plasma glucose was determined by using a commercially available kit (Peridochrom, Boehringer Mannheim, Sydney, Australia). Serum insulin was determined by using a rat-specific RIA (LINCO Research, St. Charles, MO). Total IGF-I (endogenous rat IGF-I plus rhIGF-I) concentrations were determined by RIA, as previously described (17) . The polyclonal antibody used in the assay for total IGF-I was shown to react equipotently with recombinant rat IGF-I and rhIGF-I (data not shown).
Data treatment and statistical analysis. Results are presented as means Ϯ SE. Levene's test was performed to ensure homogeneity of variance together with the Kolmogorov-Smirnov (Lilliefors) test to check for normality of the data (SPSS 8.0 software, Chicago, IL). All data presented satisfied the above tests, and, therefore, parametric analysis was employed.
With the use of a 2 ϫ 2 factorial design, with the factors being exercise and IGF-I treatment, each at two levels (with or without), ANOVA of means and interactions of factors were examined (SPSS 8.0). If statistically significant differences were detected by ANOVA, individual comparisons were made between groups by using the post hoc Fisher's least significant difference test. Pearson's correlation coefficients were calculated between serum insulin levels and the rate of protein turnover and ubiquitin-proteasome-dependent activity, and between rates of proteolysis in incubated muscles and proteasome activities and ATP-dependent casein hydrolysis in crude muscle extracts. The ␣-level was set at 0.05.
RESULTS
Effect of exercise and IGF-I on body and muscle weights.
Five days of treadmill exercise significantly reduced the normal rate of body weight increase (17.1 Ϯ 2.6 and 38.7 Ϯ 2.5 g, means Ϯ SE for the combined exercise and nonexercise groups; P Ͻ 0.001, 2-way ANOVA). IGF-I treatment had no effect on body weight, and there was no interaction between IGF-I and exercise (results not shown).
In general, exercise and IGF-I treatment had little effect on absolute muscle weights (data not shown) and muscle weights relative to body weight (Table 1) , although there was a small (8%) but significant increase in relative soleus muscle weight with exercise (2-way ANOVA).
Effect of exercise and IGF-I on rates of protein synthesis and proteolysis in incubated muscles.
Five days of treadmill exercise and/or IGF-I treatment had no effect on the rate of mixed muscle protein synthesis 24 h after the last exercise bout (Fig. 1) . In contrast, exercise training resulted in a 23% decrease in the rate of proteolysis in incubated epitrochlearis muscles 24 h postexercise (2-way ANOVA) (Fig. 1) . IGF-I treatment had no effect on protein breakdown 24 h postexercise, and there was no interactive effect between the two treatments (P ϭ 0.345; 2-way ANOVA).
Validation of proteasome activity in crude muscle extracts. The assay conditions (pH 8.0, EDTA, EGTA, protease inhibitors) were chosen to allow measurement of chymotrypsin-like (ChT-L) activity of the proteasome without interference from other major proteases. To assess the specificity of the assay, a number of control experiments were performed on extracts from gastrocnemius muscles. First, to assess the efficiency of isolating the proteasome fraction, the pellet and the supernatant resulting from the 100,000 g centrifugation step were assayed for proteasome activity by using Suc-LLVY-AMC. More than 99% of the activity present in the crude homogenate was located in the pellet, and this activity was almost completely inhibited (95-100%) by the proteasome inhibitor lactacystin (data not shown). Second, the degradation of Suc-LLVY-AMC by the crude extract was not affected by inhibitors of cysteine and serine protease (E64d or PMSF, respectively; data not shown). These experiments confirmed that, under the incubation conditions utilized, the proteasome is the major protease responsible for hydrolysis of the fluorogenic substrate by the crude muscle extracts.
Effect of exercise and IGF-I on proteasome activity in skeletal muscles. Five days of treadmill exercise significantly decreased ChT-L activity of the proteasome in gastrocnemius, soleus, and EDL muscles at 24 h postexercise (Fig. 2) . The magnitude of the suppression of the proteasome activity (21-23%) was similar to the suppression of total proteolysis in the incubated epitrochlearis muscles (24%) (compare Figs. 1 and 2) . rhIGF-I treatment had no effect on the ChT-L activity of the proteasome. There was a significant correlation between proteasome activity in muscle extracts and the rate of proteolysis in incubated muscles (gastrocnemius, r ϭ 0.377, P ϭ 0.033; soleus, r ϭ 0.421, P ϭ 0.016; EDL, r ϭ 0.513, P ϭ 0.003).
Effect of exercise and IGF-I on ubiquitin-proteasomedependent proteolysis in skeletal muscle. In this study, the activity of the ubiquitin-proteasome proteolytic pathway was assessed by measuring the degradation of [methyl- 14 C]casein by extracts of gastrocnemius muscles from exercised and IGF-I-treated rats ( Table  2 ). The rates of casein degradation approximately doubled with the addition of exogenous ATP and ubiquitin for all treatment groups, highlighting the importance of these two factors in regulating the activity of this proteolytic pathway. Muscle extracts from exercised rats had significantly less proteolytic activity, with and without added ATP/ubiquitin, compared with nonexercised rats. In contrast, there was no effect of IGF-I treatment on casein degradation. The addition of the proteasome inhibitor lactacystin decreased the rate of proteolysis by the muscle extracts to levels well below those observed in the absence of ATP/ubiquitin and lactacystin. Furthermore, when the proteasome was inhibited, the exercise-associated decrease in proteolysis was no longer present. These results indicate that the lower rate of casein degradation in the muscle extracts from exercised vs. nonexercised rats is entirely due to a decrease in the activity of the ubiquitinproteasome proteolytic pathway. In addition, it would appear that, under the in vitro conditions used in this experiment, the ubiquitin-proteasome proteolytic pathway in muscle is responsible for at least 80% of the total rate of casein degradation. There was a significant correlation between ATP-dependent casein hydrolysis and the rate of proteolysis in incubated muscles (r ϭ 0.485, P ϭ 0.03).
Effect of exercise and IGF-I on the expression of components of the ubiquitin-proteasome pathway. Representative Northern blots for the 20S proteasome subunit ␤-1, ubiquitin, and the 14-kDa E2 ubiquitin-conjugating enzyme in rat gastrocnemius muscle are shown in Fig. 3 . The level of expression for each transcript was quantified densitometrically by using the Fig. 3 . Endurance training and IGF-I treatment had no effect on the mRNA levels of the 20S proteasome subunit ␤-1 (HCY), ubiquitin (Ub), or the 14-kDa E2 ubiquitin-conjugating enzyme in rat gastrocnemius muscle. Representative Northern blots are shown. Northern blots were performed as described in MATERIALS AND METHODS. Values are means Ϯ SE in ng ⅐ mg protein Ϫ1 ⅐ min Ϫ1 of a single muscle extract from 5 rats per treatment group. Incubations were performed with (ϩ) and without (Ϫ) ATP (5 mM), ubiquitin (Ub; 2.5 g/ml), and lactacystin (Lac; 50 M) as described in MATERIALS AND METHODS. * Significant effect of exercise (P Ͻ 0.005) but not IGF-I treatment on the rate of [methyl-
14 C]casein degradation (2-way ANOVA). Fig. 2 . Chymotrypsin-like proteasomal activity in crude extracts of gastrocnemius (A), soleus (B), and extensor digitorum longus (C) muscles. Data are means Ϯ SE for 7-8 rats per treatment (based on a single muscle extract/rat). Chymotryptic activity of the proteasome was measured by using Suc-Leu-Leu-Val-Tyr-7-amino-4-methycoumarin, as described in MATERIALS AND METHODS. * Significant effect of exercise but not IGF-I treatment on activity in all 3 muscles (P Ͻ 0.005; 2-way ANOVA).
18S rRNA signals to correct for small variations in RNA loading (data not shown). There was no significant difference among groups (P Ͼ 0.05, ANOVA) for the expression of ubiquitin, 14-kDa E2, or the ␤-1 20S proteasome subunit.
Effect of exercise and IGF-I on serum insulin, IGF-I, and glucose. Serum insulin, glucose, and IGF-I concentrations were measured 24 h postexercise (see Table 3 ). At 24-h postexercise, there was no significant effect of exercise training or IGF-I treatment on serum glucose or total IGF-I (endogenous and exogenous) levels (2-way ANOVA). However, exercise-training and IGF-I treatment significantly decreased insulin concentrations 24 h after the final exercise bout, but there was no interactive effect between the two treatments (P ϭ 0.704, 2-way ANOVA). There was also no significant correlation between insulin levels and the rate of proteolysis in incubated muscles or the ubiquitin-proteasome pathway activities in the crude muscle extracts (P Ͼ 0.1, r ϭ 0.23).
DISCUSSION
Exercise effects. There is a biphasic response of protein turnover to exercise. During endurance exercise of sufficient duration and intensity, there is a net loss of muscle protein, which is followed by a period of net positive protein balance, resulting in maintenance or a slight increase in muscle mass (23) . It is commonly thought that the postexercise-positive protein balance is mediated largely through a postexercise increase in protein synthesis that is augmented by a rapid return of proteolysis to basal levels (23) . The results of the present study suggest that a suppression of proteolysis and the ubiquitin-proteasome proteolytic pathway after endurance exercise to below basal levels may contribute to the postexercise net protein gain.
The activity of the proteasome and the ubiquitinproteasome proteolytic pathway were assessed in crude muscle extracts by measuring the hydrolysis of an artificial proteasome substrate (Suc-LLVY-AMC) and the ATP-dependent hydrolysis of casein, respectively. The hydrolysis of Suc-LLVY-AMC does not require prior ubiquitinylation, whereas casein needs to be ubiquitinylation before it can undergo ATP-dependent proteasomal degradation (19) . Therefore, the rate of ATP-dependent degradation of casein is a measure of the total functional capacity of the ubiquitin-proteasome proteolytic pathway in the crude muscle extracts. This includes both the multistep process of ubiquitinylation and the degradation of the polypeptide chain by the 26S proteasome complex. That proteasome activity and ATP-dependent degradation of casein in crude extracts were significantly correlated with the exercise-induced suppression of proteolysis in incubated muscles strongly suggests that the ubiquitin-proteasome proteolytic pathway was at least partially responsible for the suppression of proteolysis 24 h postexercise. Further work is required to determine whether this effect is mediated at the level of ubiquitin conjugation and/or the protease activity of the 26S proteasome itself.
There is little information regarding the effect of exercise on the ubiquitin-proteasome system. Some investigators have suggested that this pathway is activated in the postexercise period (22, 27) . However, this conclusion was based solely on either free ubiquitin levels in muscle (27) or proteasomal activities in muscle extracts (22) . Others have shown a decrease in the mRNA levels of components of the ubiquitin-proteasome pathway in muscles from spinal cord injury patients after 12 wk of exercise training (31) . In the present study, there was no effect of exercise training on muscle expression of ubiquitin, the 14-kDa E2 conjugating enzyme, or the ␤-1 subunit of the 20S proteasome in muscle 24 h postexercise. The reasons for the discrepancies among studies are unclear but may be due to the length of exercise training or differences among species. Regardless, it would appear that changes in the level of mRNA expression were not responsible for the suppression of proteasome activity or ubiquitin-proteasome proteolytic activity observed in the present study. Lack of correlation between mRNA levels and the rate of proteolysis in muscle has been observed in a number of previous studies (9, 13) . Furthermore, Lecker et al. (18) recently showed that there was a disparity between mRNA levels of 14-kDa E2 and E3␣ and the activities of these enzymes in muscles from diabetic rats. These findings emphasize difficulties in extrapolating changes in levels of mRNA expression with enzyme activity for the ubiquitin-proteasome pathway in skeletal muscle and highlight the need for studies examining the site(s) of regulation of this pathway in vivo.
The mediators of the hypertrophic effect of exercise are still incompletely understood. It is known that nutritional intake has a major influence on the postexercise hypertrophic response. Indeed, exercise leads to an enhanced nutrient-induced increase and decrease in muscle protein synthesis and proteolysis, respectively (23) . The postprandial increase in circulating amino acids appears to be largely responsible for the enhanced rate of protein synthesis after exercise (4), whereas both insulin and amino acids have been reported to diminish the postexercise response of muscle protein breakdown (4, 5) . In the present study, exercise suppressed insulin concentrations, and there was no significant correlation between insulin levels and the rate of proteolysis or the ubiquitin-proteasome pathway activities in the crude muscle extracts. Therefore, Values are means Ϯ SE of 9-10 rats for each parameter. * Significant effect of exercise (P ϭ 0.032) and IGF-I (P ϭ 0.013) on serum insulin concentrations (2-way ANOVA).
it is unlikely that insulin was responsible for the suppression of total proteolysis and the ubiquitin-proteasome pathway 24 h postexercise. Further studies are required to explore the potential mechanisms for suppression of proteolysis during recovery from exercise.
IGF effects. The reasons for the lack of effect of rhIGF-I on muscle weight and muscle protein turnover in this study are unclear. The IGF-I dosing regimen used in this study was based on the studies of Roy et al. (24) in hypophysectomized hindlimb-suspended rats, where IGF-I treatment combined with exercise reduced the loss of muscle tissue. It is possible that, in animals with normal levels of IGF-I, such as the rats in the present study, supplemental IGF at the dose used is unable to increase the rate of muscle growth or effect changes in muscle protein turnover.
The present results suggest that the ubiquitin-proteasome pathway may be actively suppressed in situations in which there is a net gain of muscle protein such as in the postexercise period. The mechanism(s) for this effect is unclear, but it is unlikely to be simply due to changes in insulin concentrations. These results add to the recent studies implicating the ubiquitinproteasome pathway in the process of myofibrillar degradation and remodeling during muscle contraction and after exercise (20, 26) .
